Bioavailability, Safety, and Tolerability of BIS-001 ER
Clinical trial NCT03156439 · COMPLETED
Trial details
- NCT number
- NCT03156439
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-22
- Primary completion
- 2017-09-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.